These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34335605)

  • 1. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
    Prokop JW; Hartog NL; Chesla D; Faber W; Love CP; Karam R; Abualkheir N; Feldmann B; Teng L; McBride T; Leimanis ML; English BK; Holsworth A; Frisch A; Bauss J; Kalpage N; Derbedrossian A; Pinti RM; Hale N; Mills J; Eby A; VanSickle EA; Pageau SC; Shankar R; Chen B; Carcillo JA; Sanfilippo D; Olivero R; Bupp CP; Rajasekaran S
    Front Immunol; 2021; 12():694243. PubMed ID: 34335605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations.
    de Almeida Chuffa LG; Freire PP; Dos Santos Souza J; de Mello MC; de Oliveira Neto M; Carvalho RF
    J Mol Med (Berl); 2022 Feb; 100(2):285-301. PubMed ID: 34741638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
    Gardinassi LG; Souza COS; Sales-Campos H; Fonseca SG
    Front Immunol; 2020; 11():1636. PubMed ID: 32670298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19.
    Zhang Q; Meng Y; Wang K; Zhang X; Chen W; Sheng J; Qiu Y; Diao H; Li L
    Front Immunol; 2021; 12():631226. PubMed ID: 33679778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations.
    Yang X; Zhu J; Wang Q; Tang B; Shen Y; Wang B; Ji L; Liu H; Wuchty S; Zhang Z; Dong Y; Liang Z
    mSystems; 2024 Jun; 9(6):e0138523. PubMed ID: 38752789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
    Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
    Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.
    Poma AM; Basolo A; Bonuccelli D; Proietti A; Macerola E; Ugolini C; Torregrossa L; Alì G; Giannini R; Vignali P; Santini F; Toniolo A; Basolo F
    Thyroid; 2021 Dec; 31(12):1766-1775. PubMed ID: 34541878
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape.
    Mukund K; Nayak P; Ashokkumar C; Rao S; Almeda J; Betancourt-Garcia MM; Sindhi R; Subramaniam S
    Front Immunol; 2021; 12():738073. PubMed ID: 34721400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic
    Sfikakis PP; Verrou KM; Ampatziadis-Michailidis G; Tsitsilonis O; Paraskevis D; Kastritis E; Lianidou E; Moutsatsou P; Terpos E; Trougakos I; Chini V; Manoloukos M; Moulos P; Pavlopoulos GA; Kollias G; Hatzis P; Dimopoulos MA
    Front Immunol; 2021; 12():746203. PubMed ID: 34675930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
    Li S; Duan X; Li Y; Li M; Gao Y; Li T; Li S; Tan L; Shao T; Jeyarajan AJ; Chen L; Han M; Lin W; Li X
    Aging (Albany NY); 2021 Mar; 13(7):9265-9276. PubMed ID: 33780352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.
    Aschenbrenner AC; Mouktaroudi M; Krämer B; Oestreich M; Antonakos N; Nuesch-Germano M; Gkizeli K; Bonaguro L; Reusch N; Baßler K; Saridaki M; Knoll R; Pecht T; Kapellos TS; Doulou S; Kröger C; Herbert M; Holsten L; Horne A; Gemünd ID; Rovina N; Agrawal S; Dahm K; van Uelft M; Drews A; Lenkeit L; Bruse N; Gerretsen J; Gierlich J; Becker M; Händler K; Kraut M; Theis H; Mengiste S; De Domenico E; Schulte-Schrepping J; Seep L; Raabe J; Hoffmeister C; ToVinh M; Keitel V; Rieke G; Talevi V; Skowasch D; Aziz NA; Pickkers P; van de Veerdonk FL; Netea MG; Schultze JL; Kox M; Breteler MMB; Nattermann J; Koutsoukou A; Giamarellos-Bourboulis EJ; Ulas T;
    Genome Med; 2021 Jan; 13(1):7. PubMed ID: 33441124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
    Kouwaki T; Nishimura T; Wang G; Oshiumi H
    Front Immunol; 2021; 12():700926. PubMed ID: 34249006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of SARS-CoV-2 haplotypes and genomic sequences during 2020 in Victoria, Australia, in the context of putative deficits in innate immune deaminase anti-viral responses.
    Lindley RA; Steele EJ
    Scand J Immunol; 2021 Nov; 94(5):e13100. PubMed ID: 34940992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2.
    Hoffmann M; Willruth LL; Dietrich A; Lee HK; Knabl L; Trummer N; Baumbach J; Furth PA; Hennighausen L; List M
    Sci Rep; 2024 Feb; 14(1):2808. PubMed ID: 38307916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing.
    Zhao P; Zou J; Zhou F; Zhu Y; Song Q; Yu D; Li X
    Int Immunopharmacol; 2022 Jul; 108():108767. PubMed ID: 35453072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.
    Hoagland DA; Møller R; Uhl SA; Oishi K; Frere J; Golynker I; Horiuchi S; Panis M; Blanco-Melo D; Sachs D; Arkun K; Lim JK; tenOever BR
    Immunity; 2021 Mar; 54(3):557-570.e5. PubMed ID: 33577760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.